| Ms Rebecca Y Lau, PHARMD | |
|
3555 Whipple Rd, Union City, CA 94587-1507 | |
| (510) 675-4010 | |
| Not Available |
| Full Name | Ms Rebecca Y Lau |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3555 Whipple Rd, Union City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194472589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH49448 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rebecca Y Lau, PHARMD 169 Primrose Way, Palo Alto, CA 94303-3047 Ph: (650) 867-0679 | Ms Rebecca Y Lau, PHARMD 3555 Whipple Rd, Union City, CA 94587-1507 Ph: (510) 675-4010 |
News Archive
The American Academy of Ophthalmology today unveiled the nation's first comprehensive eye disease and condition patient database. The IRIS Registry (Intelligent Research in Sight) made its debut in a presentation to 25,000 attendees during the opening session of the world's largest ophthalmic conference - the 117th Annual Meeting of the American Academy of Ophthalmology at the Ernest N. Morial Convention Center in New Orleans.
As Africa marks its own Malaria Day in recognition of the fact that it bears 90% of the deadly disease's burden, an international research coalition is working to develop a cocktail of drugs that overcomes increasing resistance to conventional treatment exhibited by the elusive parasite.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
Rutgers Professor Suzie Chen has found that riluzole, a U.S. Food and Drug Administration (FDA) approved drug used to treat Lou Gehrig's disease (ALS), slows the growth of melanoma, the most aggressive form of malignant skin cancer.
› Verified 9 days ago
Matthew Yap, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 Decoto Rd, Union City, CA 94587 Phone: 510-429-0195 | |
Tania Chopra, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3553 Whipple Rd, 3rd Floor, Med Station #4, Union City, CA 94587 Phone: 510-675-2215 | |
Yun Lin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30600 Dyer St, Union City, CA 94587 Phone: 510-475-5523 | |
Mr. Keith Hiroshi Imazumi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2504 Ascot Way, Union City, CA 94587 Phone: 510-414-0847 | |
Priscilla Mok, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3553 Whipple Rd, Union City B Pharmacy, Union City, CA 94587 Phone: 510-675-4462 | |
Dr. Meiching Wang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 32300 Dyer St, Union City, CA 94587 Phone: 510-441-9393 | |
Ms. Michelle M Leu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 Decoto Rd, Union City, CA 94587 Phone: 510-429-0195 |